Clinical trials sponsored by Jules Bordet Institute

Phase breakdown

Conditions studied

Recruiting trials led by Jules Bordet Institute

• AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
  NCT02102165 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 52 locations
• Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer
  NCT06052332 · Phase: Not applicable (e.g. observational or device study) · Ages: 70 Years and older · Sex: All (male and female) · 19 locations
• Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis
  NCT06061874 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study
  NCT06227338 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)
  NCT06150898 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.
  NCT07370597 · Phase: Not specified · Ages: No age limits stated · Sex: Male · 1 location
• Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.
  NCT06523634 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 13 locations
• Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)
  NCT06925984 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 5 locations
• The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA)
  NCT06867588 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
  NCT07451483 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Jules Bordet Institute recruiting for?

Jules Bordet Institute is the lead sponsor of 10 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.